Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Theratechnologies Inc Announces Completion Of NASDAQ Delisting


Tuesday, 5 Feb 2013 08:34am EST 

Theratechnologies Inc announced that the delisting of its common shares on the NASDAQ Global Market (NASDAQ) is completed. Theratechnologies' common shares continue trading on the Toronto Stock Exchange (TSX) under the trading symbol TH. On January 14, 2013, The Company announced that it intent to voluntarily delist the Company common shares from the NASDAQ and a Form 25 was subsequently filed on January 28, 2013, with the Securities and Exchange Commission (SEC). Notwithstanding the delisting of the Company common shares from the NASDAQ. 

Company Quote

0.475
0.0050 +1.06%
30 Jul 2014